Lobe Sciences Ltd.
LOBEF
$0.0225
-$0.0003-1.32%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -39.90% | -100.21% | -36.17% | 40.33% | 72.20% |
| Total Depreciation and Amortization | -- | -100.00% | 61.72% | 5,150.00% | 2,200.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 341.03% | 1,187.23% | -249.37% | 1.27% | -93.53% |
| Change in Net Operating Assets | -33.98% | -49.73% | -71.65% | 37.92% | 538.22% |
| Cash from Operations | -154.61% | 97.78% | -160.92% | 94.53% | 91.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | 404.18% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 1,861.90% | 503.16% | -- | -- |
| Foreign Exchange rate Adjustments | 2,700.00% | -666.67% | 6,200.00% | -733.33% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -124.93% | 132.98% | -95.81% | 84.94% | 79.81% |